RICARDO CALVO

EDISON, NJ NPI 1356384705

General Payments — all program years on this page

$4,683.22

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 113
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $2,070.95 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,362.4319
Travel and Lodging $708.522

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
CVRx Inc. $1,347.708
Acerta Pharma LLC $286.643
HEARTFLOW, INC. $182.673
E.R. Squibb & Sons, L.L.C. $103.831
Amgen Inc. $80.942
Exact Sciences Corporation $32.732
Astellas Pharma US Inc $21.361
PFIZER INC. $15.081

By program year

Program yearAmountRecords
2018 $202.8214
2019 $220.9416
2020 $361.8019
2021 $327.749
2022 $1,256.3123
2023 $242.6611
2024 $2,070.9521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101841508 E.R. Squibb & Sons, L.L.C. $103.83 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110531657 AstraZeneca Pharmaceuticals LP $99.70 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110532866 AstraZeneca Pharmaceuticals LP $93.47 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110538865 AstraZeneca Pharmaceuticals LP $93.47 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115477561 Amgen Inc. $14.81 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115477569 Amgen Inc. $66.13 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128383258 Exact Sciences Corporation $16.50 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128383262 Exact Sciences Corporation $16.23 08/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132029411 PFIZER INC. $15.08 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139325938 Astellas Pharma US Inc $21.36 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151589644 CVRx, Inc. $414.00 05/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1151589648 CVRx, Inc. $294.52 05/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1151589652 CVRx, Inc. $260.34 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151589657 CVRx, Inc. $93.89 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151589661 CVRx, Inc. $146.62 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151790225 CVRx, Inc. $12.00 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151790227 CVRx, Inc. $12.63 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151790229 CVRx, Inc. $113.70 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154180566 HEARTFLOW, INC. $16.60 04/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154180568 HEARTFLOW, INC. $147.94 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154180570 HEARTFLOW, INC. $18.13 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.